RNA binding proteins (RBP) play a central role in cellular metabolism by orchestrating the complex interactions of coding, non-coding, structural and regulatory RNA species. We have found that Scaffold attachment factor protein 1 (SAFB1) play an important role in regulating neuronal function [1,2]. Importantly, SAFB1 regulates the neuronal stress response, dendritic spine formation, associate with DICER, TRBP and Ago2 complexes and thereby regulate the expression of miRNAs that control synaptic plasticity [1,2]. Furthermore, we recently found that (i) SAFB1 binding to Ataxin 1 RNA was increased in the presence of a disease-causing CAG expansion; (ii) SAFB1 expression was increased in the nucleus and abnormally expressed in the cytoplasm of cerebellar and striatal neurons of spinocerebellar ataxia (SCA) and Huntington’s disease patients respectively [3]. We also found that SAFB protein expression was changed early in the disease process [2]. As SAFB proteins are important for neuronal function we hypothesise that the altered expression observed in HD and SCAs will contribute significantly to disease pathology. The aim of this PhD is to characterise the SAFB1 dependent molecular mechanisms by which neurodegeneration is mediated and concurrently identify and explore novel therapeutic strategies.
Aims and Objectives
We hypothesise that the altered SAFB protein function observed in HD and SCAs contributes significantly to disease pathology. We wish to characterise the SAFB1 dependent molecular mechanisms by which neurodegeneration is mediated and concurrently identify and explore novel therapeutic strategies. To achieve this we will complete the following overlapping research objectives and investigate:
- The regulation SCA1 and HTT expression, expansion and toxicity by SAFB proteins
- How the stress response elicited by SCA and HD neurons is modified by SAFB proteins
Methodology
To characterise SAFB1 dependent neurodegeneration and identify and explore novel therapeutic strategies the student will use established CRISPR-Cas9 technology to knockout SAFB1 in SCA1 patient induced pluripotent stem cell (hiPSCs) lines. Cerebellar neurons will then be derived from the knockout SCA patient and isogenic control lines and used to investigate how SAFB1 regulates:
- The processing, expression and toxicity of SCA1 genes carrying a CAG expansion. Mini genes, RT-PCR, immunocytochemical, western and lentiviral constructs expressing tagged SAFB1 deletion mutants and transgenes will be used to investigate how SAFB proteins influence the splicing, expression levels, movement and localisation of SCA1. Toxicity assays and imaging techniques will be used to measure neuronal viability.
- Governs the ability of SCA and HD neurons to mediate a stress response: The neuronal stress response is attenuated in polyglutamine disease, and this may be due to altered SAFB protein expression. The student will hence use immunocytochemical and western blotting to measure the abnormal stress response and the ability of SAFB proteins to correct this in neurons derived from SAFB1 knockout SCA1 patient and control hiPSCs. The student will gain experience in several cutting-edge techniques that will give them skills desirable to academia and the pharmaceutical industry.
Keywords
Ago2, RNA binding proteins, polyglutamine diseases, SAFB1, microRNAs
How to apply for this project
This project will be based in Bristol Medical School - Translational Health Sciences in the Faculty of Health Sciences at the University of Bristol.
Please visit the Faculty of Health Sciences website for details of how to apply
Continue with Facebook
